1,001
Views
16
CrossRef citations to date
0
Altmetric
Review

A Systematic Literature Review of the Humanistic Burden of COPD

ORCID Icon, ORCID Icon, , , ORCID Icon &
Pages 1303-1314 | Published online: 10 May 2021

References

  • Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2021 report. 2021; Available from: https://goldcopd.org/wp-content/uploads/2020/11/GOLD-REPORT-2021-v1.0-16Nov20_WMV.pdf. Accessed February 3, 2021.
  • Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095–2128. doi:10.1016/S0140-6736(12)61728-0
  • James SL, Abate D, Abate KH, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789–1858.
  • Roth GA, Abate D, Abate KH, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1736–1788.
  • World Health Organization. Burden of COPD. 2019; Available from: https://www.who.int/respiratory/copd/burden/en/. Accessed November 7, 2019.
  • Molfino NA. Genetic predisposition to accelerated decline of lung function in COPD. Int J Chron Obstruct Pulmon Dis. 2007;2(2):117.
  • Lopez AD, Shibuya K, Rao C, et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J. 2006;27(2):397–412. doi:10.1183/09031936.06.00025805
  • Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442. doi:10.1371/journal.pmed.0030442
  • Brusselle G, Price D, Gruffydd-Jones K, et al. The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK. Int J Chron Obstruct Pulmon Dis. 2015;10:2207–2217. doi:10.2147/COPD.S91694
  • Gill TM, Feinstein AR. A critical appraisal of the quality of quality-of-life measurements. JAMA. 1994;272(8):619–626. doi:10.1001/jama.1994.03520080061045
  • Moons P, Van Deyk K, Budts W, De Geest S. Caliber of quality-of-life assessments in congenital heart disease: a plea for more conceptual and methodological rigor. Arch Pediatr Adolesc Med. 2004;158(11):1062–1069. doi:10.1001/archpedi.158.11.1062
  • Burge S, Wedzicha JA. COPD exacerbations: definitions and classifications. Eur Respir J. 2003;21(Supplement 41):46s–53s. doi:10.1183/09031936.03.00078002
  • Knolle M, Challis B, Pearce L, Laroche C, Pulimood T. Admission avoidance by hospital at home for exacerbations of COPD by a nurse led team in the east of England. Am J Respir Crit Care Med. 2011;183(1):1073–1449.
  • Garrido PC, de Miguel Díez J, Gutiérrez JR, et al. Negative impact of chronic obstructive pulmonary disease on the health-related quality of life of patients. Results of the EPIDEPOC study. Health Qual Life Outcomes. 2006;4(1):31. doi:10.1186/1477-7525-4-31
  • Almadana V, Sanchez J, Gómez-Bastero A, Valido A, Pavón M, Montemayor T. COPD assessment test (CAT) in the evaluation of COPD. Eur Respir J. 2012;40.
  • Chen J, Wong CK, McGhee SM, Pang PK, Yu WC. A comparison between the EQ-5D and the SF-6D in patients with chronic obstructive pulmonary disease (COPD). PLoS One. 2014;9(11):e112389. doi:10.1371/journal.pone.0112389
  • Dhamane AD, Witt EA, Su J. Associations between COPD severity and work productivity, health-related quality of life, and health care resource use: a cross-sectional analysis of national survey data. J Occup Environ Med. 2016;58(6):e191–e197. doi:10.1097/JOM.0000000000000735
  • Dignani L, Toccaceli A, Lucertini C, Petrucci C, Lancia L. Sleep and quality of life in people with COPD: a descriptive-correlational study. Clin Nurs Res. 2016;25(4):432–447. doi:10.1177/1054773815588515
  • Esteban C, Quintana JM, Egurrola M, et al. Classifying the severity of COPD: are the new severity scales better than the old? Int J Tuberc Lung Dis. 2009;13(6):783–790.
  • Joo MJ, Lee TA, Bartle B, van de Graaff WB, Weiss KB. Patterns of healthcare utilization by COPD severity: a pilot study. Lung. 2008;186(5):307–312. doi:10.1007/s00408-008-9095-5
  • Mewes R, Rief W, Kenn K, Ried J, Stenzel N. Psychological predictors for health-related quality of life and disability in persons with chronic obstructive pulmonary disease (COPD). Psychol Health. 2016;31(4):470–486. doi:10.1080/08870446.2015.1111369
  • Moro JMR-G, Izquierdo JL, Antón E, de Lucas P, Martín A, Group MS. Health-related quality of life in outpatient women with COPD in daily practice: the MUVICE Spanish study. Respir Med. 2009;103(9):1303–1312. doi:10.1016/j.rmed.2009.04.002
  • Soler-Cataluña JJ, Sauleda J, Valdés L, et al. Prevalence and perception of 24-hour symptom patterns in patients with stable chronic obstructive pulmonary disease in Spain. Arch Bronconeumol. 2016;52(6):308–315. doi:10.1016/j.arbres.2015.11.010
  • Vaz Fragoso CA, McAvay G, Van Ness PH, et al. Phenotype of spirometric impairment in an aging population. Am J Respir Crit Care Med. 2016;193(7):727–735. doi:10.1164/rccm.201508-1603OC
  • Wacker ME, Jorres RA, Karch A, et al. Assessing health-related quality of life in COPD: comparing generic and disease-specific instruments with focus on comorbidities. BMC Pulm Med. 2016;16(1):70. doi:10.1186/s12890-016-0238-9
  • Wiklund I, Berry P, Lu KX, Fang J, Fu C. The Chinese translation of COPD assessment test™ (CAT) provides a valid and reliable measurement of COPD health status in Chinese COPD patients. Am J Respir Crit Care Med. 2010;181(1).
  • Wu M, Zhao Q, Chen Y, Fu C, Xu B. Quality of life and its association with direct medical costs for COPD in urban China. Health Qual Life Outcomes. 2015;13:57. doi:10.1186/s12955-015-0241-5
  • Gupta N, Pinto L, Benedetti A, et al. The COPD assessment test: can it discriminate across COPD subpopulations? Chest. 2016;150(5):1069–1079. doi:10.1016/j.chest.2016.06.016
  • Merino M, Villoro R, Hidalgo-Vega Á, Carmona C. Health-related quality of life of patients diagnosed with COPD in extremadura, Spain: results from an observational study. Health Qual Life Outcomes. 2019;17(1):1–10. doi:10.1186/s12955-019-1244-4
  • Beaumont M, Couturaud F, Jego F, et al. Validation of the French version of the London chest activity of daily living scale and the dyspnea-12 questionnaire. Int J Chron Obstruct Pulmon Dis. 2018;13:1399–1405. doi:10.2147/COPD.S145048
  • Bonfitto I, Moniello G, Pascucci M, et al. Mood disorders in elderly patients hospitalized for acute exacerbation of COPD. J Gerontol. 2017;4:13.
  • Fernández-García S, Represas-Represas C, Ruano-Raviña A, et al. Social and clinical predictors associated with prolonged hospital stays for patients with severe exacerbation of chronic obstructive pulmonary disease. Rev Clin Esp. 2020;220(2):79–85. doi:10.1016/j.rce.2019.05.003
  • Ivziku D, Clari M, Piredda M, De Marinis MG, Matarese M. Anxiety, depression and quality of life in chronic obstructive pulmonary disease patients and caregivers: an actor–partner interdependence model analysis. Qual Life Res. 2019;28(2):461–472. doi:10.1007/s11136-018-2024-z
  • Vaske I, Kenn K, Keil DC, Rief W, Stenzel NM. Illness perceptions and coping with disease in chronic obstructive pulmonary disease: effects on health-related quality of life. J Health Psychol. 2017;22(12):1570–1581. doi:10.1177/1359105316631197
  • Xiang Y, Wong T, Tsoh J, et al. Quality of life in older patients with chronic obstructive pulmonary disease (COPD) in Hong Kong: a case‐control study. Perspect Psychiatr Care. 2015;51(2):121–127. doi:10.1111/ppc.12073
  • Yang Y, Li Q, Mao J, Mao Z. Fatigue and health‐related quality of life among patients with chronic obstructive pulmonary disease in China. Clin Respir J. 2020;14(2):109–115. doi:10.1111/crj.13107
  • Zhou Z, Zhou A, Zhao Y, Duan J, Chen P. A comparison of the assessment of health status between CCQ and CAT in a Chinese COPD clinical population: a cross-sectional analysis. Int J Chron Obstruct Pulmon Dis. 2018;13:1675. doi:10.2147/COPD.S161225
  • Bourbeau J, Ford G, Zackon H, Pinsky N, Lee J, Ruberto G. Impact on patients’ health status following early identification of a COPD exacerbation. Eur Respir J. 2007;30(5):907–913. doi:10.1183/09031936.00166606
  • Di Marco F, Verga M, Reggente M, et al. Anxiety and depression in COPD patients: the roles of gender and disease severity. Respir Med. 2006;100(10):1767–1774. doi:10.1016/j.rmed.2006.01.026
  • Yeo J, Karimova G, Bansal S. Co-morbidity in older patients with COPD–its impact on health service utilisation and quality of life, a community study. Age Ageing. 2006;35(1):33–37. doi:10.1093/ageing/afj002
  • Lopez-Campos JL, Fernandez-Villar A, Calero-Acuna C, et al. Evaluation of the COPD assessment test and GOLD patient types: a cross-sectional analysis. Int J Chron Obstruct Pulmon Dis. 2015;10:975–984. doi:10.2147/COPD.S82781
  • Lawrence PJ, Kolsum U, Gupta V, et al. Characteristics and longitudinal progression of chronic obstructive pulmonary disease in GOLD B patients. BMC Pulm Med. 2017;17(1):42. doi:10.1186/s12890-017-0384-8
  • Han MK, Muellerova H, Curran-Everett D, et al. GOLD 2011 disease severity classification in COPDGene: a prospective cohort study. Lancet Respir Med. 2013;1(1):43–50. doi:10.1016/S2213-2600(12)70044-9
  • Adams S, Fan V, Nguyen H, et al. Clinical outcomes in chronic obstructive pulmonary disease are associated with perception of dyspnea more than exacerbation risk or disease severity measured by lung function. Chest. 2012;142(4):676A. doi:10.1378/chest.1389751
  • Chen Y, Yao W, Kang J, et al. Distribution and significance of GOLD 2011 disease severity classification in patients with COPD in China: a national cross-sectional survey. Eur Respir J. 2013;42:P1870. doi:10.1183/09031936.00046013
  • Kelly J, Crowley O, Smith C, et al. Determinants of the COPD assessment test (CAT) score in clinical practice. Am J Respir Crit Care Med. 2011;183(1).
  • Sloots JM, Barton CA, Buckman J, et al. The predictive value of an adjusted COPD assessment test score on the risk of respiratory-related hospitalizations in severe COPD patients. Chron Respir Dis. 2017;14(1):72–84. doi:10.1177/1479972316687099
  • Feliz-Rodriguez D, Zudaire S, Carpio C, et al. Evolution of the COPD assessment test score during chronic obstructive pulmonary disease exacerbations: determinants and prognostic value. Can Respir J. 2013;20(5):e92–e97. doi:10.1155/2013/398120
  • Solem CT, Sun SX, Sudharshan L, Macahilig C, Katyal M, Gao X. Exacerbation-related impairment of quality of life and work productivity in severe and very severe chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2013;8:641–652. doi:10.2147/COPD.S51245
  • McKellar A, Cottrell WN, Whelan A. BODE score is a useful predictor of hospital admission in rural patients with chronic obstructive pulmonary disease. Respirology. 2008;13(3):438–443. doi:10.1111/j.1440-1843.2007.01169.x
  • Esteban C, Quintana J, Moraza J, et al. Impact of hospitalisations for exacerbations of COPD on health-related quality of life. Respir Med. 2009;103(8):1201–1208. doi:10.1016/j.rmed.2009.02.002
  • McGlone S, Venn A, Walters EH, Wood-Baker R. Physical activity, spirometry and quality-of-life in chronic obstructive pulmonary disease. COPD. 2006;3(2):83–88. doi:10.1080/15412550600651263
  • Ramon MA, Esquinas C, Barrecheguren M, et al. Self-reported daily walking time in COPD: relationship with relevant clinical and functional characteristics. Int J Chron Obstruct Pulmon Dis. 2017;12:1173–1181. doi:10.2147/COPD.S128234
  • Krishnan G, Grant BJ, Muti PC, et al. Association between anemia and quality of life in a population sample of individuals with chronic obstructive pulmonary disease. BMC Pulm Med. 2006;6:23. doi:10.1186/1471-2466-6-23
  • Menn P, Weber N, Holle R. Health-related quality of life in patients with severe COPD hospitalized for exacerbations– comparing EQ-5D, SF-12 and SGRQ. Health Qual Life Outcomes. 2010;8:39. doi:10.1186/1477-7525-8-39
  • Kühl K, Schurmann W, Rief W. Mental disorders and quality of life in COPD patients and their spouses. Int J Chron Obstruct Pulmon Dis. 2008;3(4):727–736. doi:10.2147/COPD.S3375
  • Jackson B, Coultas DB, Russo R, et al. Health impact of pain among a representative sample of outpatients with COPD. Am J Respir Crit Care Med. 2014;189.
  • Lou P, Zhu Y, Chen P, et al. Prevalence and correlations with depression, anxiety, and other features in outpatients with chronic obstructive pulmonary disease in China: a cross-sectional case control study. BMC Pulm Med. 2012;12:53. doi:10.1186/1471-2466-12-53
  • Shah A, Ayas N, Tan WC, et al. Sleep quality and nocturnal symptoms in a community-based COPD cohort. COPD. 2020;17(1):40–48. doi:10.1080/15412555.2019.1695247
  • World Bank Country and Lending Groups. 2021; Available from: https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups. Accessed January 20, 2021.
  • Meng Q, Mills A, Wang L, Han Q. What can we learn from China’s health system reform? BMJ. 2019;365:l2349. doi:10.1136/bmj.l2349
  • Zhu B, Wang Y, Ming J, Chen W, Zhang L. Disease burden of COPD in China: a systematic review. Int J Chron Obstruct Pulmon Dis. 2018;13:1353–1364. doi:10.2147/COPD.S161555
  • World Health Organization. Chronic obstructive pulmonary disease (COPD). 2017. Available from: https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd). Accessed November 4, 2019.
  • Battisti WP, Wager E, Baltzer L, et al. Good publication practice for communicating company-sponsored medical research: GPP3. Ann Intern Med. 2015;163(6):461–464. doi:10.7326/M15-0288